le Polain de Waroux, J., Ploux, S., Mondoly, P., Eschalier, R., Strik, M., Houard, L., . . . Bordachar, P. (2018). Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter–defibrillator to confirm appropriate ventricular fibrillation detection. Heart Rhythm, 15(5), 642. https://doi.org/10.1016/j.hrthm.2018.02.013
Παραπομπή σε μορφή Chicago (17η εκδ.)le Polain de Waroux, Jean-Benoit, et al. "Defibrillation Testing Is Mandatory in Patients with Subcutaneous Implantable Cardioverter–defibrillator to Confirm Appropriate Ventricular Fibrillation Detection." Heart Rhythm 15, no. 5 (2018): 642. https://doi.org/10.1016/j.hrthm.2018.02.013.
Παραπομπή σε μορφή MLA (9th εκδ.)le Polain de Waroux, Jean-Benoit, et al. "Defibrillation Testing Is Mandatory in Patients with Subcutaneous Implantable Cardioverter–defibrillator to Confirm Appropriate Ventricular Fibrillation Detection." Heart Rhythm, vol. 15, no. 5, 2018, p. 642, https://doi.org/10.1016/j.hrthm.2018.02.013.